PRGO (PRGO)
Quantitative Summary
DeterministicFinancial health is average: Piotroski 4/9.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe fundamental economics of the business are currently characterized by significant operational distress, evidenced by a negative ROIC spread and an ROE decomposition driven primarily by severe margin contraction rather than turnover or leverage inefficiencies. While asset utilization remains moderate at 0.50x, the -33.5% net margin is eroding returns to such an extent that even with nearly three times equity leverage, shareholders face substantial value destruction. Financial robustness metrics reflect this deterioration; a Piotroski F-Score of 4/9 suggests weak financial health relative to peers, whereas a Beneish M-Score of -3.55 indicates low probability of earnings manipulation but does not offset the underlying profitability crisis. The combination of shrinking revenue (-2.8% YoY) and negative returns on invested capital signals that current operations are failing to generate sufficient cash flow to sustain equity value under standard valuation frameworks.
Valuation multiples appear detached from fundamental reality given the persistent losses, making traditional P/E comparisons with historical averages or sector benchmarks mathematically inapplicable without significant caveats regarding future recovery scenarios. Since earnings are negative, DCF models relying on terminal growth assumptions become highly sensitive to discount rate inputs and projected margin stabilization rather than current cash flows. The market pricing likely reflects a binary view: either an imminent turnaround that could restore the gross-to-net margin spread or continued structural decline where leverage amplifies losses rather than magnifying returns. Without evidence of improving operating levers, any implied growth rates in valuation models would need to be exceptionally optimistic to justify current price levels against the backdrop of negative ROIC and declining top-line performance.
Risk factors are further highlighted by stagnant insider activity over the last 90 days, with zero net flow suggesting a lack of conviction from management regarding near-term catalysts or confidence in the turnaround trajectory. While the low Beneish score mitigates concerns about accounting fraud, it does not compensate for the fundamental delta represented by negative ROIC and shrinking revenues, which typically correlate with higher downside volatility in equity markets. The absence of positive insider positioning combined with deteriorating DuPont components creates a risk-reward profile where potential upside is heavily contingent on unproven operational fixes, while downside risks remain anchored to the current inability to generate positive returns on capital employed.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
⚠️ Dividend consumes >80% of FCF — sustainability risk.
DuPont Analysis — ROE Decomposition
Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like XPH or SLYV, the fund manager is mechanically forced to buy or sell PRGO shares regardless of PRGO's individual fundamentals. We estimate $48M of passive capital is structurally linked to PRGO through 8 tracked ETFs. Passive flows have a limited but growing influence on PRGO's daily trading dynamics.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in PRGO to visualize passive redemption contagion across ETFs and collateral stocks.
If PRGO (PRGO) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies ORGANON + CO (OGN) as the most exposed collateral stock, sharing 3 ETFs with PRGO. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 9 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
PRGO Ownership Dynamics
ETFs with Highest PRGO Exposure
Float lock-up computed from 10 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-14 | 1,776 | $10.91 | $19,376.16 |
| 2026-05-13 | 1,839 | $11.12 | $20,449.68 |
| 2026-05-11 | 101,080 | $11.71 | $1.2M |
| 2026-05-07 | 2,182 | $12.26 | $26,751.32 |
| 2026-05-04 | 3,653 | $11.92 | $43,543.76 |
| 2026-04-28 | 16,660 | $11.49 | $191,423.4 |
| 2026-04-23 | 5,048 | $11.82 | $59,667.36 |
| 2026-04-22 | 2,026 | $11.73 | $23,764.98 |
| 2026-04-17 | 127 | $11.42 | $1,450.34 |
| 2026-04-14 | 7,624 | $11.31 | $86,227.44 |
| 2026-04-09 | 704 | $10.83 | $7,624.32 |
| 2026-04-06 | 5,693 | $10.85 | $61,769.05 |
| 2026-04-02 | 9,907 | $11.00 | $108,977 |
| 2026-03-27 | 6 | $9.38 | $56.28 |
| 2026-03-25 | 15,982 | $9.64 | $154,066.48 |
| 2026-03-24 | 16,073 | $9.57 | $153,818.61 |
| 2026-03-23 | 520 | $9.25 | $4,810 |
| 2026-03-19 | 3,821 | $9.94 | $37,980.74 |
| 2026-03-18 | 23,907 | $10.30 | $246,242.1 |
| 2026-03-02 | 88,855 | $13.22 | $1.2M |
| 2026-02-25 | 332 | $14.61 | $4,850.52 |
| 2026-02-18 | 33,169 | $14.44 | $478,960.36 |
| 2026-02-11 | 2,789 | $14.39 | $40,133.71 |
| 2026-02-10 | 8,713 | $14.32 | $124,770.16 |
| 2026-02-02 | 701 | $14.21 | $9,961.21 |
| 2026-01-30 | 233 | $13.74 | $3,201.42 |
| 2026-01-26 | 7 | $14.72 | $103.04 |
| 2026-01-23 | 7 | $15.08 | $105.56 |
| 2026-01-13 | 15,112 | $14.94 | $225,773.28 |
| 2026-01-09 | 42 | $14.70 | $617.4 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Compare PRGO to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.